HLMN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Hillman Solutions Corp. is not a good buy right now for a beginner long-term investor with $50,000-$100,000 to deploy. The stock has some supportive signals from hedge fund buying and a generally positive analyst stance, but the current technical trend is still weak, recent earnings were mixed, and insider selling is rising. At the current pre-market price of 8.16, I would not call this an immediate buy; the better call is to hold and wait for stronger price confirmation or clearer fundamental improvement.
HLMN is in a bearish setup. The MACD histogram is negative and expanding, showing downside momentum is still building. The moving averages are bearish with SMA_200 > SMA_20 > SMA_5, which confirms a broader downtrend. RSI_6 at 23.061 indicates the stock is oversold, but not yet showing a reliable reversal signal. Price is currently below the pivot at 8.567 and only slightly above support at 8.097, so the stock is sitting near support rather than breaking out. The short-term pattern suggests some near-term bounce potential, but the overall trend remains weak.
["Hedge funds are buying, with buying amount up 144.03% over the last quarter.", "Analysts still maintain Buy ratings across recent updates.", "Q1 2026 revenue increased 3% year over year to $370.1 million.", "The company maintained adjusted EBITDA guidance for FY2026 at $275 million to $285 million.", "Options positioning is heavily call-skewed, which suggests bullish sentiment."]
["Q1 adjusted EBITDA fell 8% year over year to $50.1 million.", "Q1 non-GAAP EPS missed expectations.", "FY2026 net sales guidance was lowered to $1.63 billion to $1.73 billion.", "Gross margin declined to 35.48%, down 4.70% year over year.", "Insiders are selling, with selling amount up 145.90% over the last month.", "Technical trend is bearish with price below key moving averages and negative MACD momentum."]
In Q1 2026, Hillman posted revenue of $370.1 million, up 2.99% year over year, which shows modest top-line growth. However, profitability weakened: adjusted EBITDA declined 8% to $50.1 million, gross margin fell to 35.48%, and non-GAAP EPS missed expectations at $0.07. Net income remained negative at -$4.73 million. Overall, this was a mixed quarter with growth continuing but margin and earnings pressure visible.
Wall Street remains constructive overall, but target prices have been trimmed. Stifel cut its target to $12 from $12.20 while keeping a Buy rating and said it has a positive overall view. Benchmark lowered its target to $14 from $15, also keeping Buy, and described the stock as a buyer of dips after solid Q4 results and a conservative outlook. Canaccord also cut its target to $14 from $15 and kept Buy after mixed Q4 results. The pros view is still favorable, but recent target cuts show some caution around near-term execution and guidance.
